Study of Pharmacokinetics for Ivermectin B1a from Beagle Dogs
Journal of Chromatographic Science · 2025
DOI: 10.1093/chromsci/bmad092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chromatographic Science, 2025. Verfasst von Yuyang Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Guangzhou Medical University, Xinzao, Panyu District, Guangzhou, Guangdong 511436, China. Hauptthemen laut MEDLINE: Ivermectin, Antiparasitic Agents. Die Arbeit nennt 17 Literaturangaben. Gefördert von: Science and Technology Bureau of Qingyuan City, Guangdong Province, China, Qingyuan High-tech Zone, East China University of Science and Technology.
Abstract (Originalsprache)
Ivermectin has been widely used for antiparasitic drug, and has recently shown a broad-spectrum antiviral activity, including anti-Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the pharmacokinetic property of ivermectin has not been fully investigated yet. During the plasma preparation, ~32–46% of ivermectin was found in the precipitation. An Liquid Chromatograph-Mass Spectrometer (LC–MS/MS) method for ivermectin in the whole blood samples from beagle dogs was developed and validated. The specificity, accuracy, precision (intra-day and inter-day), matrix effect, recovery and stability of analyte reported here are satisfied with the criteria of Food and Drug Administration (FDA)-Bioanalysis guideline. The oral administrations pharmacokinetics of ivermectin in beagle dogs under fasting and after high-fat meal were studied, and the following parameters were obtained: fasting Cmax, 104 ± 35 μg·L−1; area under the concentration–time curve (AUC0–∞), 2,555 ± 941 h·μg·L−1; and high-fat meal Cmax, 147 ± 35 μg·L−1; AUC0–∞, 4,198 ± 1,279 h·μg·L−1. When the P-gp inhibitor curcumin was also coadministrated orally, Cmax and AUC0–∞ were found to be 177 ± 57 and 4,213 ± 948 h·μg·L−1, respectively. With the comparison to fasting treatment, coadministration of P-gp inhibitor curcumin resulted in increase of the exposure of ivermectin by 1.6-fold, while the exposure after the high-fat diet versus fasting was increased approximately in 1.4-fold, indicating that alternative absorption might play an important role for increasing the exposure of ivermectin for future clinic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Guangzhou Medical University, Xinzao, Panyu District, Guangzhou, Guangdong 511436, China.
- Guangdong Ruigu Biotech Corporation, 18 Chuangxing Road, High-tech Zone, Qingyuan, Guangdong 511517, China.
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Meilong Road, Xuhui District, Shanghai 200237, China.
ORCID-Profile: Renke Dai
Förderung
- Science and Technology Bureau of Qingyuan City, Guangdong Province, China
- Qingyuan High-tech Zone
- East China University of Science and Technology
Zitieren
APA
Chen, Y., Huang, X., Guo, Z., Zhang, J., Zhang, L., & Dai, R. (2025). Study of Pharmacokinetics for Ivermectin B1a from Beagle Dogs. Journal of Chromatographic Science. https://doi.org/10.1093/chromsci/bmad092
Vancouver
Chen Y, Huang X, Guo Z, Zhang J, Zhang L, Dai R. Study of Pharmacokinetics for Ivermectin B1a from Beagle Dogs. Journal of Chromatographic Science. 2025. doi:10.1093/chromsci/bmad092
BibTeX
@article{Chen2025,
author = {Chen, Yuyang and Huang, Xiaofang and Guo, Zizheng and Zhang, Jingyu and Zhang, Lixin and Dai, Renke},
title = {Study of Pharmacokinetics for Ivermectin B1a from Beagle Dogs},
journal = {Journal of Chromatographic Science},
year = {2025},
doi = {10.1093/chromsci/bmad092}
}
EUVIMED